Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

AmBev Agrees to Merge with Interbrew


Brazil's Companhia de Bebidas das Americas (known as AmBev) (ABV) and Belgium's Interbrew agreed to merge in an $11.2 billion deal. The combined InterbrewAmBev would command 14% of the global beer market. Terms: Interbrew will hold 21.8% economic interest in AmBev and 52.8% voting interest; AmBev will acquire Interbrew's Labatt unit. (3/3)

Genzyme Corp. (GENZ) says it signed a definitive agreement to become the "stalking horse" in the auction to acquire certain assets of bankrupt outfit Impath -- namely its physician services unit which provides oncology testing -- for $215 million in cash. (3/1)

Genzyme Corp. (GENZ) agrees to acquire Ilex Oncology (ILXO) for $26 per share in GENZ stock. (2/26)

Silver Acquisition Corp. agrees to buy Gold Banc (GLDB) for $16.60 per share. (2/25)

Jones Apparel Group (JNY) makes an unsolicited bid for Maxwell Shoe (MAXS) of $20 per share. (2/25)

Golden State Vintners (VINT) gets two bids, including one bid from a group of existing holders that includes CEO Jeffrey B. O'Neill. It did not disclose terms. (2/24)

Synopsys (SNPS) agrees to buy Monolithic System Technology (MOSY) for $13.50 per share in cash and stock. (2/24)

Clinical Data (CLDA) offers to buy Moore Medical (MMD). Terms: 0.698 CLDA share for each MMD share. (2/24)


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus